Popular Articles

Karen Burgin, CNM, MA, Named To American College Of Nurse-Midwives Fellowship
Karen Black Burgin, CNM, MA, of Montclair, New Jersey was inducted into the Fellowship of the American College of Nurse-Midwives (FACNM) at the ACNM"s 54th Annual Meeting in Seattle this past spring.

ACOG Issues New Guidelines On Fetal Monitoring To Resolve Inconsistencies In Interpretation
The American College of Obstetrics and Gynecology recently published new guidelines on electronic fetal monitoring in an attempt to increase consistency in the way physicians interpret and act on the results, the New York Times reports. Electronic fetal monitoring, which was introduced in the 1970s, is used during labor for more than 85% of the four million infants born alive in the U.S. annually, the Times reports. According to the Times, use of fetal monitors became standard obstetrical practice before it was known if the benefits outweighed the risks. The new guidelines refine the meaning of various readings from fetal monitors and could help doctors make better decisions about whether to intervene during labor.According to experts, the widespread adoption of fetal monitoring has produced both negative and positive consequences, including significant increases in caesarean deliveries and the use of forceps during vaginal deliveries. Monitoring has not been found to reduce the risk of either cerebral palsy or fetal death resulting from inadequate oxygen to the fetal brain, as it was intended to do. Furthermore, lawyers commonly use monitoring results to support malpractice cases that might have little merit, which in turn has driven rising malpractice insurance costs and prompted some obstetricians to stop delivering infants.The new guidelines divide monitor readings into three categories to help doctors interpret readings more consistently. The old guidelines had two categories -- reassuring and non-reassuring -- and it was up to the obstetrician to determine whether a non-reassuring reading required intervention. Under the new guidelines, the first category applies when tracings of the fetal heart rate are normal and no specific action is required. The second category is for indeterminate tracings that require evaluation, continuous surveillance and re-evaluation. Obstetricians treating patients in this category should consider other clinical factors that could affect the fetus and whether the patient could be safely moved to category one, according to Catherine Spong of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, which produced recommendations on which the guidelines are based. The final category is for abnormal tracings that require immediate evaluation and efforts to reverse the abnormal heart rate. The Times reports that more refinements to the guidelines are expected to be released in 2010 (Brody, New York Times, 7/7).
News of the day
American Cancer Society To Recognize Corporate Employers Changing The Course Of The Cancer Fight
The American Cancer Society - the nation"s leading voluntary health organization and largest non-governmental funder of cancer research and discovery - will present its Corporate Impact Awards June 19 during the Society-hosted Corporate Impact Conference in Chicago. The awards will recognize companies" engagement in targeted efforts to significantly impact cancer"s effect on the workplace, where disease-related expenditures and lost productivity costs annually surpass $228 billion; in contributing funds to the American Cancer Society to fight the disease; and in addressing responsible community involvement.
Sexual Health

Government Responds To Archer Inquiry

The Government today responded to the independent inquiry into contaminated blood supplies in the 1970s and 1980s. In a Written Ministerial Statement, Public Health Minister Dawn Primarolo set out the Government"s response to the Archer Inquiry into individuals infected by HIV and hepatitis C through infected NHS blood and blood products. The response includes: - there will be a significant increase in annual payments to ÷£12,800 for individuals infected with HIV, in addition to the ÷£45 million already given out in lump sums and discretionary payments; - further support for the Haemophilia Society of ÷£100,000 per year for the next five years; and - a commitment to review the financial relief for individuals affected by hepatitis C in five years. Tough measures are already in place to prevent similar events happening in the future. To ensure all patients with bleeding disorders who may have been infected have been identified, a look back exercise will be undertaken. Minister for Public Health, Dawn Primarolo said: "I would like to offer my deepest sympathy to all those who suffered in this tragic episode. Sadly, it was not possible to effectively test for these viruses in the 1970s and early 80s and we deeply regret that these events occurred following NHS treatment. "Steps to safeguard blood products against HIV and hepatitis C have been in place since 1985. Every reasonable step to minimise risks from blood transfusion has been taken and robust screening measures are in place to protect patients. "In addition to the ÷£150 million already given out in lump sums and discretionary payments to those infected with HIV and hepatitis C, financial help for those infected with HIV will rise to ÷£12,800 per year." The full response to Lord Archer"s report has been placed in the Library of the House. In keeping with the Government"s commitment to make information available that relates to this period, the remaining 468 relevant documents have been placed on the Department of Health website. The Macfarlane Trust and Eileen Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):